BrainStorm Cell Therapeutics Taps Haro Hartounian Ph.D. as COO, Effective June 18
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the appointment of Hartoun Hartounian Ph.D. as its new EVP